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Abstract
 
ParkinsonÕs disease (PD) is defined by the progressive loss of dopaminergic
neurons. Mitochondrial dysfunction and oxidative stress are associated with PD
although it is not fully understood how neurons respond to these stresses. How
adaptive and apoptotic neuronal stress response pathways are regulated and the
thresholds at which they are activated remains ambiguous. Utilising SH-SY5Y
neuroblastoma cells, we show that MAPK/AP-1 pathways are critical in regulating the
response to mitochondrial uncoupling. Here we found the AP-1 transcription factor c-
Jun can act in either a pro- or anti-apoptotic manner, depending on the level of
stress. JNK-mediated cell death in differentiated cells only occurred once a threshold
of stress was surpassed. We also identified a novel feedback loop between Parkin
activity and the c-Jun response, suggesting defective mitophagy may initiate
MAPK/c-Jun-mediated neuronal loss observed in PD. Our data supports the
hypothesis that blocking cell death pathways upstream of c-Jun as a therapeutic
target in PD may not be appropriate due to crossover of the pro- and anti-apoptotic
responses. Boosting adaptive responses or targeting specific aspects of the neuronal
death response may therefore represent more viable therapeutic strategies.
 
 
 
 
 
 
 
 
 
1. Introduction
 
ParkinsonÕs disease (PD) is a neurodegenerative disorder characterised by
the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc).
Although oxidative stress and mitochondrial dysfunction are prominent
 
ParkinsonÕs disease (PD) is a neurodegenerative disorder characterised by
the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc).
Although oxidative stress and mitochondrial dysfunction are prominent
characteristics of familial and sporadic PD, the precise pathways driving pathological
changes are yet to be fully defined.
 
A number of studies have implicated immediate early gene (IEG) signalling in
PD (1-9). IEG proteins, such as Fos and Jun transcription factors, are regulators of
the early stress response. Fos and Jun proteins dimerise to form activating protein-1
(AP-1) transcription factor complexes, which regulate the expression of genes
containing the TPA responsive element (TRE) consensus sequence (5Õ-
TGA(G/C)TCA-3Õ) within their promoter (10, 11). Increased activity of the AP-1
transcription factor c-Jun, a downstream target of c-Jun amino N-terminal kinase
(JNK), has been found in dopaminergic neurons of PD patients (1), although JNK
inhibition in clinical trials has yet to yield positive results (12). AP-1 activity and
stability can be rapidly modulated by phosphorylation in response to stimuli (13), with
JNK, an AP-1 regulator, implicated in several neurodegenerative conditions (14).
 
The MAPK, extracellular signal-regulated kinase (ERK) can regulate the
activity of JNK and c-Jun (15, 16), has been implicated in the mitochondrial stress
response (17, 18) and regulates the neuronal response to different forms of L-DOPA-
induced oxidative stress via c-Jun (9). With the complexity of crosstalk, coupled with
signal-dependent thresholds, it seems probable that multiple pathways coordinate
adaptive and apoptotic stress responses in neurons. Even specific stress response
mechanisms can share common elements or be activated in parallel (19). Cells
initiate protective or apoptotic responses depending on the level or duration of stress.
The capacity of the initial response dictates the eventual outcome (20). In post-
mitotic neurons, adaptive responses are critical since their failure will lead to
progressive neurodegeneration.
 
Most intracellular reactive oxygen species (ROS) are produced by
mitochondria (21). Excessive ROS associated with PD are produced by dysfunctional
mitochondria, which undergo selective autophagy, a process called mitophagy (22).
The PARK2 (PARKIN) and PARK6 genes (encoding Parkin and PTEN-induced
putative kinase 1 (PINK1), respectively) are linked to familial PD (23), with PARKIN
mutations the most common cause of autosomal-recessive PD (24, 25). Upon
mitochondrial depolarisation, PINK1 accumulates on the mitochondrial outer
membrane (MOM), recruiting and activating the E3 ubiquitin ligase Parkin (26-28) to
promote mitophagy (29). Excessive ROS activates the apoptosis signalling kinase 1
(ASK1)/JNK pathway (30-33). As Parkin activity can repress JNK/c-Jun activity (4,
34) and c-Jun represses PARKIN expression (7), a feedback loop may exist between
multiple pathways to determine the response to these stresses.
 
Here we define the role played by MAPK/AP-1 pathways in the response to
mitochondrial uncoupling, utilising SH-SY5Y neuroblastoma cells (35, 36). Our data
suggests a finely balanced system in which feedback loops between c-Jun, Parkin
and MAPK activity exist, allowing neurons to rapidly respond to mitochondrial
damage and commit to apoptosis if irreversibly damaged. Dysfunction within this
multi-faceted process may drive some neurodegenerative pathologies.
 
2. Materials and methods
 
2.1. Cell culture
Wild type (WT) and Parkin overexpressing SH-SY5Y neuroblastoma cell lines
were obtained from Dr Phil Robinson (37), the latter created by stable transfection of
a pcDNA3.1/Hygro(+) vector (Invitrogen, Paisley, UK) containing PARKIN cDNA into
cells followed by hygromycin B selection (Invitrogen). Cells were used between
passage 7-16 and grown in DMEM/F12 GlutaMAXTM media supplemented with 10%
FCS, 100µg/ml penicillin, 100µg/ml streptomycin and minimum essential media non-
essential amino acids (Gibco, Paisley, UK) at 37¡C and 5% CO2. For differentiation,
cells were seeded in standard culture medium for 24 hours, then incubated in
medium containing 10µM retinoic acid (RA) for 3 days. RA medium was removed,
cells washed with PBS then serum-free medium containing 50ng/ml brain derived
neurotrophic factor (BDNF) added for 3 days. HEK293 cell lines (38) were cultured in
DMEM with 10% FCS, 100µg/ml penicillin and 100µg/ml streptomycin (Gibco).
 
2.2. Antibodies
neurotrophic factor (BDNF) added for 3 days. HEK293 cell lines (38) were cultured in
DMEM with 10% FCS, 100µg/ml penicillin and 100µg/ml streptomycin (Gibco).
 
2.2. Antibodies
Antibodies specific for c-Jun (5B1, ab119944), JunD (EPR6520, ab134067),
JunB (EPR6518, ab128878), c-Fos (2G2, ab129361), FosB (83B1138, ab11959),
Fra-1 (EP4711, ab124722), Fra-2 (EPR4713(2), ab124830), anti-mitochondria
[MTCO2] (ab3298) and Histone H3 (1791, ab1791) were obtained from Abcam
(Cambridge, UK). Anti-Parkin (Prk8) (4211), -c-Fos (9F6, 2250) and -phosphorylated
c-Jun (Ser63) II (9261) obtained from Cell Signalling Technology (Hertfordshire, UK).
Anti-β-actin (A5441) was obtained from Sigma. Horseradish-peroxidase anti-mouse
(P0260) and anti-rabbit (P0448) secondary antibodies were supplied by Dako
(Stockport, UK). Highly-cross adsorbed (H+L) Alexa Fluor 488 anti-mouse (A11029)
and Alexa Fluor 594 anti-rabbit (A11037) secondary antibodies from Molecular
Probes, Invitrogen.
 
2.3. Cell proliferation assay
Cells were trypsinised, resuspended in medium then stained with trypan blue
and counted using a Countessª (Invitrogen). 2 x 105 cells/well were seeded and
incubated at 37¡C for 72 hours. Cells were split and resuspended, then counts
performed using a Countessª.
 
2.4. CCCP assays
Cells were seeded 24 hours before CCCP (Sigma, UK) was added to medium
with gentle mixing. Cells scraped into PBS at specific time points and centrifuged at
200xg for 5 min. Pellets frozen at -80¡C for protein extraction. Epoxomicin (Santa
Cruz Biotechnology, CA, USA) was added 1 hour prior to CCCP addition and
SP600125 (JNK inhibitor; Santa Cruz Biotechnology) or FR180204 (ERK inhibitor;
Sigma) added 2 hours prior to CCCP.
 
2.5. Western blotting
Cell pellets were resuspended in ice-cold radioimmunoprecipitation assay
buffer (RIPA) buffer (1% Nonidet-P-40, 0.5% sodium deoxycholate and 0.1% SDS in
PBS) containing 1X Halt Protease and Phosphatase Inhibitor Cocktail (Pierce,
Northumberland, UK) and 5mM EDTA, then left on ice for 30 min. Samples were then
centrifuged at 14800xg for 10 min at 4¡C and 5µl of supernatant used for a Bradford
Assay (BioRad, Hertfordshire, UK) to determine protein concentrations. Remaining
supernatant mixed with equal volume of 2X SDS loading buffer containing 0.2M DTT
and frozen at -20¡C for western blotting.
 
Using a Mini-Protean II electrophoresis cell (Bio-Rad), protein extracts were
subjected to Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) at 100V in running buffer (25mM Tris base, 250mM glycine, 0.1% SDS).
Protein was transferred to Hybond-C extra nitrocellulose membrane (Amersham,
Buckinghamshire, UK) at 100V for 90 min in transfer buffer (25mM Tris base, 192mM
glycine, 20% methanol, 0.01% SDS). Membranes were blocked in 5% (w/v) milk in
PBS for one hour at room temperature (RT) then incubated with primary antibodies
prepared at 1:1000 dilutions (β-actin at 1:2000) in block overnight at 4¡C.
Membranes were washed 6 times in PBS-T then incubated with a 1:2000 dilution of
horseradish peroxidase-conjugated secondary antibody in block for 1 hour at RT.
Membranes were washed 6 times in PBS-T then once in PBS. Target antigens
detected using enhanced chemiluminescence Super Signal West Pico or Femto
reagents (Pierce) on a ChemiDoc MP Imaging System with Image Lab 4.0.1 (Bio-
Rad) for densitometry.
 
2.6. Immunofluorescence and CellROX¨ assays
Cells grown on methanol-sterilised glass coverslip were treated as required
then medium removed and washed in PBS, then incubated at RT for 20 min in 4%
paraformaldehyde (PFA), washed 3 times in PBS and permeabilised with PBS-0.1%
Triton X-100 for 5 min. If required, CellROX¨ Reagent was added to medium at a
final concentration of 5µM 30 minutes prior to fixation. Cells were washed 3 times in
PBS then blocked in 0.1% milk powder in PBS for 30 min. Primary antibodies were
prepared at 1:1000 dilutions (MTCO2 at 1:500) in block and centrifuged. Coverslips
were incubated with primary antibody solutions for 1 hour at RT then washed 3 times
in PBS. Secondary antibodies were prepared at 1:500 dilutions in block (DAPI
1:1000) and centrifuged prior to 1 hour incubation with coverslips, which were
washed 3 times in PBS after 1 hour. Coverslips mounted using Mowiol.
Immunostaining was observed using a Nikon Eclipse Ti upright microscope
in PBS. Secondary antibodies were prepared at 1:500 dilutions in block (DAPI
1:1000) and centrifuged prior to 1 hour incubation with coverslips, which were
washed 3 times in PBS after 1 hour. Coverslips mounted using Mowiol.
Immunostaining was observed using a Nikon Eclipse Ti upright microscope
supported by NIS Elements software.
 
2.7. High-throughput immunofluorescence
Cells were grown and treated in 96-well ViewPlates (PerkinElmer, Berkshire,
UK). Fixation, permeabilisation and staining scaled down from above method before
PBS added to each well. Plates were processed using the Operetta high-
content/high-throughput (HC/HT) wide-field fluorescence imaging system with
Harmony software (PerkinElmer) with 20X or 40X objectives (10 or 17 fields of view
per well, respectively). Up to 3 fluorescent channels were imaged. Focal planes
determined at the start of each experiment. Images were analysed using Columbus
software (PerkinElmer) in a non-biased manner. Objects around border of fields of
view were excluded. The DAPI channel was used to detect nuclei (>30µm2 with
contrast of over 0.10). Cell counts performed by Columbus software counting nuclei.
TOTO3 imaged using far-red illumination. Mitochondria detected using Alexa Fluor
488.
 
2.8. siRNA knockdown
siRNA SMARTpools obtained from Dharmacon specific to JUN (c-JUN) (M-
003268-03-0005), JUNB (M-003269-01-00), JUND (M-003900-05-0005), FOS (c-
FOS) (M-003265-01-0005), FOSB (M-010086-03-0005), FOSL1 (FRA-2) (M-004341-
04-0005), FOSL2 (FRA-2) (M-004110-00-0005) and PARK2 (PARKIN) (M-003603-
00-0005). siRNA specific to non-targeting 1 (NT1) and polo-like kinase 1 (PLK1) were
used as negative and positive transfection controls, respectively. A BLAST search
was performed (http://blast.ncbi.nlm.nih.gov/Blast.cgi) for individual siRNAs in
SMARTpools to predict for off-target effects. Final siRNA concentration was 50nM
and carried out in duplicate. RNAiMAX transfection reagent mix was made up in
Opti-MEM serum free medium according to manufacturerÕs instructions. Cells were
seeded at 4,000 cells/well using a Fluid-X Xrd-384 dispenser and incubated for 48
hours with siRNA at 37¡C in 96 well plates.
 
2.9. RNA extraction and RT-qPCR 
RNA isolation was performed by according to the TRIzol¨ manufacturersÕ
protocol (Life Technologies), with 1µl of RNase-free glycogen per sample prior to
isopropanol and TURBO DNase kit (Ambion, UK) according to the manufacturersÕ
protocol. To quantify RNA, a NanoDrop¨ ND-1000 Spectrophotometer (Thermo
Scientific, Loughborough, UK) was used. A 500ng dilution of RNA was made up in
5µl of RNase-free water, then heated to 65¡C for 5 minutes after addition of 1µl
random hexamers, 1µl dNTP mix (10mM dA, dC, dG and dT) and 7µl RNase-free
water. After 2 minutes on ice, samples were centrifuged then 4µl of 5X 1st strand
buffer, 1µl 0.1M DTT and 1µl of SuperScript III reverse transcriptase (200U/µl) were
added and incubated for 5 minutes. Samples were heated to 50¡C for 50 minutes,
followed by 70¡C for 15 minutes before cooling on ice.
 
Reactions were run in duplicate in a MicroAmp¨ Optical 96-well Reaction
Plate (Applied Biosystems, Warrington, UK) with a 20µl final volume in each well (1µl
of 20X Taqman¨ Gene Expression Assay, 10µl of 2X Taqman¨ Gene Expression
Master Mix, 7µl of RNase-free water and 2µl of 1:10 diluted cDNA) using the Taqman
recommended qPCR cycle (50¡C 2 minutes, 95¡C 10 minutes, then; 95¡C 15
seconds and annealing/extension at 60¡C for 1 minute for 40 cycles) on the ABI 7500
Real Time PCR System (Applied Biosystems) using 7500 SDS software. Primer
efficiencies were assessed. To calculate the relative expression level of a gene of
interest (GOI) the DDCt method (39) was used for primer/probe efficiencies of 100%
(-/+10%). To calculate relative expression using primers of <90% efficiency, the
standard curve method was employed (40) then incorporated as part of the Livak
method.
 
2.10. Statistical Analysis 
Independent biological repeats, denoted by ÔnÕ values, refer to complete
independent repeats of experiments. Error bars represent standard error of the mean
(SEM) or standard deviation (SD) for mean values replicates. Statistical analysis was
performed using Prism GraphPad 6 software. Appropriate tests were performed for
individual experiments with post-hoc analysis if required.
 
performed using Prism GraphPad 6 software. Appropriate tests were performed for
individual experiments with post-hoc analysis if required.
 
3. Results
 
3.1. Parkin overexpression sensitises cells to mitochondrial uncoupling.
SH-SY5Y cells were used as a neuronal-like model to study the AP-1
response to mitochondrial stress, using CCCP to induce mitochondrial uncoupling
and PINK1/Parkin-mediated mitophagy (26-29). Overexpression of Parkin was
maintained post-differentiation with RA/BDNF (Fig 1A). Several differentiation
protocols were assessed with RA/BDNF inducing the greatest neurite outgrowth (S1
Fig), a characteristic of SNpc dopaminergic neurons (41, 42), so this was chosen for
further study. In undifferentiated cells, Parkin overexpression did not alter rate of
proliferation (S1 Fig), but did sensitise cells towards differentiation (Fig 1B).
 
Parkin is generally considered cytoprotective. However, we previously
demonstrated that accelerating mitophagy through Parkin overexpression reduced
cell viability upon mitochondrial uncoupling in HEK293 cells (38). To investigate the
effect of Parkin overexpression in the SH-SY5Y stress response, undifferentiated WT
and Parkin overexpressing SH-SY5Y cells were treated with CCCP, H2O2 (cellular
oxidative stress), rotenone (complex I inhibitor) or epoxomicin (proteasomal
inhibition) for 24 hours and surviving cells counted. Parkin specifically sensitised cells
to mitochondrial uncoupling, but not other forms of stress (Fig 1C).
 
CellROX¨ Green Reagent was used to determine ROS levels over a 24 hour
period post-CCCP treatment. Treatment of cells with 5µM CCCP induced oxidative
stress, with ROS levels peaking at around 2 hours and resolving back to basal levels
by 24 hours (Fig 1D). This was cytotoxic but did not result in the death of the entire
cell population after 24h (Fig 1C), thus was chosen for further study.
 
3.2. c-Jun can act anti- or pro-apoptotically, depending on the mitochondrial
stress level.
The Nrf2-mediated antioxidant response is epigenetically repressed in some
neurons (43). AP-1-mediation of stress responses may therefore play a more pivotal
role in neurons than in other cell types. AP-1 proteins in undifferentiated and
differentiated SH-SY5Y cells were observed by immunofluorescence (S2 and S3
Figs). To investigate a functional role for AP-1 transcription factors in the
mitochondrial stress response, a targeted siRNA screen was carried out. Individual
JUN and FOS family genes, along with PARKIN, were knocked down prior to 24 hour
CCCP treatment, then cells fixed, stained for DAPI and counted (Figure 1E). NT-1, a
scrambled siRNA control, was used as a siRNA control for comparison. PLK1
knockdown, a positive control for transfection efficacy, resulted in significant cell
death. Interestingly, PARKIN knockdown did not significantly reduce cell survival after
uncoupling compared to control. c-FOS siRNA led to significant death in control cells,
accounting for lower cell numbers in the CCCP-treated group.
 
c-Jun is generally considered to be pro-apoptotic under stress conditions in
neurons (1, 7, 44-46). In contrast, c-JUN knockdown caused an increase in CCCP-
induced cell death (Figs 1F and G). However, c-JUN knockdown prior to 30mM
CCCP conversely reduced cell death (Fig 1H), suggesting a dual role for c-Jun in this
context. In cells overexpressing Parkin, knockdown of c-JUN did not alter cell
survival (Fig 1I).
 
To further characterise the c-Jun response, western blotting was carried out
over a time course. During the first 6 hours in undifferentiated WT cells, no significant
change in total c-Jun levels was observed (Fig 2A), but S63 phosphorylated c-Jun
became significantly elevated (Fig 2B), the latter even more so in differentiated cells.
Parkin overexpression appears to perturb the decline observed in WT cells after their
initial increase. Differentiation resulted in an exaggerated c-Jun response, consistent
with the hypothesis that it may be more functionally important in neuronal cells. S63
phosphorylated c-Jun/c-Jun ratios also differed between cell lines (Fig 2C).
 
Over a longer period of uncoupling c-Jun levels were elevated (Fig 3A). Due
to the sensitivity of differentiated cells to CCCP, it was only possible to examine this
up to 12 hours post-uncoupling. Phosphorylation of c-Jun was distinct in each of 3
cell lines assessed (Fig 3B), as were the phosphorylated c-Jun/c-Jun ratios (Fig 3C).
Parkin overexpression again prevented the decline observed in WT cells after their
up to 12 hours post-uncoupling. Phosphorylation of c-Jun was distinct in each of 3
cell lines assessed (Fig 3B), as were the phosphorylated c-Jun/c-Jun ratios (Fig 3C).
Parkin overexpression again prevented the decline observed in WT cells after their
initial increase Doublets of phosphorylated c-Jun were observed at 2 and 12 hours
post-CCCP in differentiated cells, suggesting additional residues were
phosphorylated. We also observed modulation of other AP-1 proteins (S4 Ð S6 Figs).
 
To monitor changes at transcriptional level, qPCR analysis was employed to
assess relative changes in mRNA levels of AP-1 genes. Expression of all 3 JUN
genes underwent modulation in response to mitochondrial uncoupling (Figs 3D &
S7). c-JUN expression was regulated in a biphasic manner, with the initial increase in
expression detected at 1 hour post-CCCP followed by a drop in mRNA levels
between 2 and 6 hours, which was then proceeded by a progressive increase.
Changes in PARKIN expression showed that the mitophagic response was regulated
at the transcriptional level (Fig 3E). To assess the potential c-Jun-mediated apoptotic
response relative mRNA levels of BIM were assessed, as BIM upregulation in
response to oxidative stress in neurons by JNK/c-Jun (47) is critical for neuronal
apoptosis (48). Mitochondrial uncoupling led to a rapid increase in BIM expression
(Fig 3F), which remained elevated throughout. These data suggested a role for c-Jun
in the neuronal response to mitochondrial stress and so we aimed to investigate this
further.
 
3.3. The c-Jun response is differentially regulated by JNK and ERK
AP-1 transcription factors undergo substantial regulation via MAPK-mediated
phosphorylation (11), with JNK considered the primary c-Jun regulator (49) We
therefore investigated the MAPK-dependent modulation of c-Jun by treating cells
with SP600125, a JNK inhibitor, or FR180204, an ERK inhibitor, prior to
mitochondrial uncoupling. It has been recently shown in SH-SY5Y cells that
uncoupling and mitochondrial ATP output is relative to CCCP concentration (50). We
therefore decided to investigate how this would affect MAPK regulation of c-Jun.
 
Under lower mitochondrial uncoupling (5mM CCCP), JNK and ERK both
acted to regulate overall c-Jun levels (Fig 4A). Although JNK inhibition prevented
phosphorylation of c-Jun S63, ERK inhibition resulted in greater phosphorylation (Fig
4B), suggesting ERK repressed JNK-mediated phosphorylation of c-Jun. Under
higher levels of uncoupling (30mM CCCP), the increase in c-Jun levels was
regulated by ERK and supressed by JNK (Fig 4C). The transient boost in c-Jun S63
phosphorylation 2 hours after uncoupling was also mediated by ERK, which again
may be antagonised by JNK (Fig 4D). JNK and ERK are therefore likely to both be
important under these conditions.
 
3.4. JNK regulates cell death under high levels of mitochondrial stress in
differentiated SH-SY5Y cells.
MAPK inhibition was then examined in differentiated SH-SY5Y cells. JNK
inhibition did not have a significant effect on cell death induced by lower uncoupling
conditions, but did have a significant effect under higher levels of uncoupling (Figs 5A
and 5B), increasing survival by around 6-fold. The lower concentration of JNK
inhibitor failed to increase cell survival, as did ERK inhibition. This is consistent with a
model in which JNK-regulated apoptosis is only initiated once a critical threshold of
mitochondrial damage is passed. Undifferentiated Parkin overexpressing cells were
significantly more sensitive to CCCP than WT cells (Fig 1C). This also appeared to
be the case in differentiated cells, even with JNK inhibition (Fig 5C).
 
Complete Parkin-dependent mitophagy requires ubiquitin-proteasome system
(UPS) activity, with proteasomal inhibition blocking Parkin activity (38, 51).
Autophagic inhibition alone does not perturb UPS-dependent degradation of outer
membrane mitochondrial proteins (52). To investigate if proteasomal dysfunction
exacerbated cell death in response to mitochondrial stress and whether this was
regulated by MAPK signalling, proteasomal inhibition was induced using epoxomicin.
This induced cell death in differentiated WT and Parkin SH-SY5Y cells, which was
not rescued by MAPK inhibition (Figs 5D and 5E). However, JNK inhibition did
rescue UPS-deficient cells also undergoing mitochondrial uncoupling.
 
Data from non-neuronal models has demonstrated that mitochondria undergo
perinuclear clustering early in mitophagy (28, 53-55). However, in neurons most
mitochondria reside within axons and may not undergo somal degradation, with
axonal lysosomes and autophagosomes observed (56-58). Inducing damage in
perinuclear clustering early in mitophagy (28, 53-55). However, in neurons most
mitochondria reside within axons and may not undergo somal degradation, with
axonal lysosomes and autophagosomes observed (56-58). Inducing damage in
axonal mitochondria leads to rapid local recruitment of Parkin and other mitophagic
machinery and localised clustering within autophagosomes (59).
 
We asked whether the inhibition of specific pathways impacted on
mitochondrial clustering upon uncoupling. Differentiated WT SH-SY5Y cells
underwent uncoupling following MAPK/proteasomal inhibition and mitochondrial
clustering was analysed 3 hours after CCCP treatment (Figs 5F, 5G and S8) with
TOTO-3 staining labelling the cytoplasm for high-throughput image analysis (60).
Uncoupling induced a significant increase in the number of mitochondrial clusters
(Fig 5G). UPS inhibition reduced mitochondrial clusters post-uncoupling. JNK
inhibition reduced mitochondrial clustering in UPS-deficient cells only at the highest
level of uncoupling, suggesting that this pathway may only be activated in response
to higher levels of mitochondrial damage. Although proteasomal inhibition
antagonised mitochondrial clustering, no significant effect was found from the
inhibition of either JNK or ERK alone. Thus, MAPK activity does not appear to
regulate mitochondrial clustering.
 
3.5. c-Jun activity under mitochondrial stress may be regulated by Parkin-
mediated mitophagy to form a regulatory feedback loop
Parkin overexpressing cells showed a greater increase in c-Jun protein levels
24 hours after mitochondrial uncoupling than WT cells (Fig 3A). c-Jun has previously
been shown to repress PARKIN expression (7). We therefore investigated the link
between c-Jun and Parkin-dependent mitophagy. As UPS activation is critical for
mitophagy, we tested the effect that proteasomal inhibition had on the c-Jun
response to mitochondrial uncoupling. c-Jun protein levels in UPS-deficient cells (Fig
6A) did not show the marginal reduction observed in the normal CCCP response (Fig
2A). Proteasomal inhibition in the absence of uncoupling did not significantly alter c-
Jun protein levels (Fig 6B), thus control levels (-/+ epoxomicin) were a comparable
basal point. Over a longer period of uncoupling, c-Jun levels became increasingly
elevated in UPS-deficient cells (Fig 6C).
 
To investigate whether a specific functional link between c-Jun and Parkin
existed, we used previously characterised HEK293 cell lines that inducibly over-
express different Parkin mutants (38). Some of these lines expressed non-functional
PD-associated PARKIN mutations (T240R, R275Y, R42C) or reduced E3 ligase
mutants (R42P), allowing us to assess whether modulation of c-Jun levels was
dependent on Parkin E3 ligase activity. Compared to untransfected cells, the
induction of WT Parkin expression and subsequent mitochondrial uncoupling resulted
in a significant increase in c-Jun protein levels (Figs 6D and 6E). Cells expressing
R42P Parkin, a functional mutant demonstrating reduced mitophagic activity (53, 61-
63) exhibited a similar c-Jun induction profile to cells expressing WT Parkin.
Expressing mutant forms of Parkin generally resulted in a down regulation of the c-
Jun response to mitochondrial uncoupling. Strikingly, inducing the expression of the
T240R mutant construct increased the c-Jun response to CCCP-induced stress.
Notably, although the R275Y, R42C and T240R mutants are all E3 ligase-deficient,
only the latter induced an elevation in c-Jun levels relative to WT Parkin upon
uncoupling.
 
4. Discussion
We aimed to investigate how neuronal decisions to initiate either adaptive or
apoptotic responses are made in response to mitochondrial stress. In particular, how
mitophagic and signalling pathways interlinked to regulate different arms of the stress
response. The SH-SY5Y neuron-like cell line was used to demonstrate the
involvement of the JNK/c-Jun pathway in dictating response to mitochondrial
dysfunction in a neuronal context. CCCP uncoupled mitochondria and induced
oxidative stress and has been shown to induce apoptosis in SH-SY5Y cells at a wide
range of concentrations (64-66). Utilising both undifferentiated and differentiated cells
allowed the identification and functional analysis of MAPK and AP-1 pathways in this
response. It also highlighted differences between these cell models, illustrating the
importance of choosing an appropriate experimental system in such work.
Furthermore, our results, along with previously published works, would suggest that
MAPK inhibition may not be an effective therapeutic strategy in vivo due to it leading
to the downregulation protective pathways, as well as the intended apoptotic
pathways.
MAPK inhibition may not be an effective therapeutic strategy in vivo due to it leading
to the downregulation protective pathways, as well as the intended apoptotic
pathways.
 
4.1. The role of c-Jun is dictated by the level of stress
While many AP-1 transcription factors underwent modulation upon
mitochondrial coupling, siRNA knockdowns suggested c-Jun can act in an anti- or
pro-apoptotic manner and that this was dependent on the level of mitochondrial
damage. This c-Jun response was differentially regulated by JNK and ERK and this
regulation was, again, dependent on the level of stress. Parkin overexpression or
differentiation towards a more neuronal-like phenotype induced significant alterations
in the early c-Jun response to mitochondrial uncoupling. Differentiation resulted in an
exaggerated c-Jun response, suggesting it may be more critical in neuronal cells.  
 
Several studies have implicated c-Jun as a pro-apoptotic factor in neuronal
and non-neuronal cells undergoing different forms of stress (44-46, 67-69). Initially
our results suggested that c-Jun was anti-apoptotic upon mitochondrial uncoupling.
Further investigation revealed that under higher levels of mitochondrial dysfunction,
c-Jun promoted apoptosis. MAPK/c-Jun activity has recently been shown to regulate
both cell death and survival under different levels of PD-associated stress (9). These
data suggest biphasic modulation of c-JUN expression may allow c-Jun signalling to
underpin responses to both lower and higher levels of mitochondrial stress and
mediate an apoptotic or cytoprotective response, as appropriate. The level of stress
would dictate how c-Jun protein levels and activity were altered. Dysregulation of this
biphasic reaction at normally non-cytotoxic levels of mitochondrial damage (e.g. due
to UPS dysfunction) could lower the threshold of stress at which c-Jun promotes
neuronal apoptosis.
 
4.2. MAPKs play a critical role in the regulation of c-Jun and the cell death
response
Our data revealed both JNK and ERK can regulate c-Jun protein levels and
phosphorylation in response to differing levels of mitochondrial stress. It is likely that
overall regulation reflects crosstalk between MAPK pathways (16), allowing
alternative c-Jun activities to be dictated. Here, JNK-dependent cell death was not
initiated by proteasomal dysfunction, but if mitochondrial depolarisation occurred in
parallel with UPS-deficiency, the JNK pathway became dominant in inducing cell
death. The idea of inhibiting MAPKs such as JNK or ERK has been extensively
explored in PD models, however, these data would suggest that inhibition upstream
of transcription factors such as c-Jun will in fact lead to the inhibition of numerous
other pathways, some of which will not be driving PD pathology.
 
JNK has been previously proposed as a therapeutic target in
neurodegenerative studies as it is generally associated with neuronal death (49, 70).
Despite JNK inhibition in animal and cell models yielding promising results, a trial in
PD patients involving the kinase inhibitor CEP-1347 was not successful (12). As JNK
signalling plays a role in synaptic plasticity (71) and neuronal development (43), as
well as our data suggesting it plays a role in the initial adaptive response, inhibition of
this whole class of kinases could perturb protective activities that are normally
functional in PD neurons. Indeed, it is likely that these endogenous protective
pathways are in fact slowing down the progression of neurodegeneration, and thus
their perturbation may accelerate disease pathology.
 
4.3. Parkin and MAPK/AP-1 signalling
Parkin activity has been linked to JNK repression (4, 34, 72-74) and can act
both pro- and anti-apoptotically, depending on the level of stress (65). Additionally,
JNK stabilises PINK1 under stress (75). Parkin overexpression increases sensitivity
to mitochondrial uncoupling in HEK293 cells (38) and SH-SY5Y cells. BIM, induced
by c-Jun to initiate neuronal apoptosis (45), may regulate crosstalk between
autophagy and apoptosis (76, 77) by promoting Parkin recruitment to mitochondria
normally perturbed by pro-survival Bcl-2 proteins (66). Indeed, BIM accumulates on
the MOM under stress to initiate BAX-dependent cytochrome c release (78).
Therefore, chronic activation of the JNK/c-Jun pathway may lead to increased BIM-
mediated recruitment of Parkin to damaged mitochondria, promoting apoptosis once
a threshold of damage is surpassed.
 
Our data suggests Parkin mutations that perturb its mitochondrial
translocation lead to exacerbation of c-Jun signaling upon uncoupling. This is
summarised in Table 1 (26, 27, 38, 53, 54, 61-63, 79-82). This perturbation may
 
Our data suggests Parkin mutations that perturb its mitochondrial
translocation lead to exacerbation of c-Jun signaling upon uncoupling. This is
summarised in Table 1 (26, 27, 38, 53, 54, 61-63, 79-82). This perturbation may
represent a potential mechanism by which c-Jun-dependent neuronal apoptosis
occurs in some PD neurons. As JNK translocation to damaged mitochondria (83)
induces neuronal apoptosis (84, 85) and  amplifies mitochondrial ROS production
(86), it may be critical step in setting the threshold at which irreversible mitochondrial
damage has occurred. Parkin could therefore function to regulate mitochondrial JNK
signaling to manage the threshold of tolerable damage. When damage levels
saturate adaptive responses, excessive mitochondrial JNK would shift the equilibrium
towards apoptosis. Therefore, specifically targeting the inhibition of mitochondrial
JNK, instead of all cellular JNK, may represent a better therapeutic target in order to
prevent any unwanted dampening of JNK-mediated cytoprotection. Indeed, this
translocation may be isoform specific, or rely on distinct phosphorylation events, to
potentially regulate apoptotic c-Jun signalling. ATF4 upregulates PARKIN expression
(7, 8) and is a critical regulator of the mitochondrial stress response (87). As c-Jun
represses ATF4-mediated PARKIN expression (7), regulatory feedback loops would
be critical in determining the appropriate pathways to activate (Fig 7). Under
excessive stress c-Jun would supress PARKIN, antagonising cytoprotective Parkin-
mediated mitophagy to facilitate apoptosis of irreversibly damaged cells. The fact we
only observed increased apoptosis in Parkin overexpressing cells treated with CCCP
and not H2O2 or rotenone indicates that this apoptotic promotion by Parkin is not due
to oxidative stress, agreeing with previous data (65). Therefore, cross-talk between
JNK/c-Jun and Parkin pathways could be critical in determining when a switch
between adaptive/apoptotic responses occurs.
 
4.4. Conclusions
Previous studies have shown Parkin to regulate MAPK signalling (4, 34).
Conversely, PARKIN expression can be regulated by the JNK/c-Jun pathway (7).
ERK has also been shown to localise to damaged mitochondria in order to
coordinate mitophagy (17). Although our data further suggests a critical role for
MAPK/AP-1 in regulating mitochondrial damage-induced cell death, it is clear from
additional studies that these pathways also regulate protective stress responses.
Therefore, simple kinase inhibition could in fact be detrimental in an in vivo setting
whereby disease progression occurs over decades due to these protective pathways
constantly activating homeostatic mechanisms.
 
Nigral dopaminergic neurons demonstrate characteristics such higher basal
levels of oxidative stress and greater axonal mitochondrial density due to increased
bioenergetic demands compared to other neurons (41). This combination of factors
potentially explains their specific degeneration in PD (42). How neuronal fate
decisions are made in relation to the type or level of stress remains relatively
unexplored. Perturbation of adaptive responses (e.g. by PARKIN mutations or non-
specific MAPK inhibition) would lower this damage threshold by which apoptosis is
activated and in cells such as nigral dopaminergic neurons that are both susceptible
to damage and non-renewable this could lead to neurodegeneration.
 
Previous studies have found that AP-1 proteins FosB, DFosB and JunD are
involved in long-term neuronal stress adaptations (88-92). Here, we focus on early
adaptive responses within a novel feedback loop whereby Parkin activity modulates
the c-Jun levels in response to mitochondrial stress, potentially relying on the
mitochondrial recruitment of Parkin. As ROS is critical in regulating neuronal function
(43, 71), it is important that stress response feedback loops in neurons function
correctly to properly differentiate between survivable and cytotoxic levels of stress.
Future work will therefore be crucial to dissect different neuronal pathways and
identify specific proteins or events, such as the mitochondrial localisation of specific
JNK isoforms and their regulation of c-Jun, that are unique to the neurodegenerative
apoptotic responses.
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 Parkin mutant
 WT R275Y T240R S131A Y143F R42P R42C R275W T415N C289G G430D C352G K161N K211N
Region of mutation n/a RING1 RING1
SH2-like
domain
SH2-like
domain
UBL
domain
UBL
domain
RING1 RING2 RING1 RING2
IBR
domain
SH2-
like
domain
SH2-
like
domain
E3 ubiquitin ligase
activity
✓ ✗ ✗ ✓ ✓ ✓ ? ✗ ✗ ? ✗ ✗ ✗ ✗
Mitophagy blocked
by proteasomal
inhibition
✓ n/a n/a ✓ ✗ ✓ n/a n/a n/a n/a n/a n/a n/a n/a
Recruited to
depolarised
mitochondria
✓ ? ✗ ✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓ ✗
Induces
mitochondrial
clustering
✓ ✗ ✗ ✓ ✓ ✓ ✓ Delayed ✓ ✗ ✗ ✗ ✗ ✓ ✗
Induces
Induces
mitochondrial
clustering
✓ ✗ ✗ ✓ ✓ ✓ ✓ Delayed ✓ ✗ ✗ ✗ ✗ ✓ ✗
Induces
mitochondrial
degradation
✓ ✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Change in c-Jun
levels 24h post-
CCCP (relative to
WT)
n/a Decrease Increase Decrease Decrease
No
change
Decrease ? ? ? ? ? ? ?
 
Table 1: Parkin mutations perturb mitophagy at different stages. Previous data
demonstrates that dysfunction occurs at different stages of mitophagy depending on the
Parkin mutant. To date, the steps at which this disruption occurs for each mutant shown here
has not been fully elucidated. Our data suggests that Parkin translocation to mitochondria
upon uncoupling may be critical in the regulation of c-Jun. Note: some studies demonstrate
contradictory data and some boxes therefore contain both ticks and crosses. n/a = not
available. Ô?Õ represents unknown.
 
Figure 1: Parkin and c-Jun play a role in CCCP-induced apoptosis. SH-SY5Y cells in
undifferentiated form or differentiated form (differentiated by 10µM retinoic acid (RA) for 3
days (10% serum) followed by 50ng/ml BDNF (no serum) for 3 days). (A) Western blot
analysis revealed Parkin overexpression was maintained post-differentiation. (B) Parkin
overexpression resulted in greater sensitivity to RA/BDNF differentiation. DAPI counts were
performed using an Operetta system (n = 3) and analysed using an unpaired two-tailed t-test
(****p < 0.001). (C) Parkin overexpression rendered undifferentiated cells more sensitive to
mitochondrial uncoupling. Cells plated at 4,000 cells/well for 24 hours were then exposed to
5µM CCCP, 50µM H
2
O
2
, 0.1µM rotenone or 100nM epoxomicin over a 24-hour period, then
fixed and stained with DAPI and counts performed on an Operetta system (n = 4). Statistical
significance was ascertained using a 2way ANOVA (BonferroniÕs) (*p<0.05, **p<0.01). (D)
Treatment of SH-SY5Y cells with 5µM CCCP induced oxidative stress. Cells were stained
with the mitochondrial marker MTCO2 (red), CellROX¨ (green) and DAPI (blue). CellROX¨
Green staining showed (E) Knockdown by siRNA SMARTpools was performed 48 hours prior
to CCCP challenge and cell counts (relative to DMSO-treated NT-1 knockdown cells)
performed on an Operetta imaging system using DAPI-stained nuclei (n = 3). A siRNA screen
of the AP-1 proteins and Parkin, using NT1 (non-targeting 1) and PLK1 (polo-like kinases) as
negative and transfection controls respectively, showed c-Jun may play a role in the cell
death response to mitochondrial uncoupling. (F) Knockdown of c-Jun was confirmed by
performed on an Operetta imaging system using DAPI-stained nuclei (n = 3). A siRNA screen
of the AP-1 proteins and Parkin, using NT1 (non-targeting 1) and PLK1 (polo-like kinases) as
negative and transfection controls respectively, showed c-Jun may play a role in the cell
death response to mitochondrial uncoupling. (F) Knockdown of c-Jun was confirmed by
western blot. Cell death for knockdowns was quantified using the Operetta system. (G) siRNA
knockdown of c-Jun resulted in increased death induced by 5µM CCCP. (H) Under 30µM
CCCP conditions, knockdown of c-Jun reduced cell death. (I) No significant alteration to the
level of cell death was observed after c-Jun was knocked down prior to uncoupling in Parkin
overexpressing cells. Statistical significance was assessed using an unpaired 2-tailed t-test
(*p<0.05). Error bars represent SEM.
 
 
 
 
Figure 2: c-Jun is rapidly modulated in response to mitochondrial uncoupling. Western
blot analysis was carried out on protein extracts obtained at specific time points after the
treatment of undifferentiated/differentiated WT or undifferentiated Parkin overexpressing SH-
SY5Y cells with 5mM CCCP over a 6 hour period. Where required, cells were differentiated
in 10µM RA for 3 days (10% serum) followed by 50ng/ml BDNF (no serum) for 3 days prior to
treatment with CCCP. Densitometry was calculated relative to the loading control (n = 3). (A)
Statistically significant changes in c-Jun protein levels were observed in Parkin and
differentiated SH-SY5Y lines. (B) Phosphorylated (S63) c-Jun levels show significant
elevation after uncoupling. (C) Average values for total c-Jun and phosphorylated (S63) c-Jun
levels were used to calculate the phospho/total c-Jun ratio over the first 6 hours of
uncoupling. Statistical significance was determined using a 2way ANOVA (DunnettÕs)
(*p<0.05, **p<0.01, ***p<0.005). Quantified levels were compared to levels at time point 0.
Error bars represent SEM.
 
 
Figure 3: The c-Jun response to mitochondrial uncoupling is variably modulated over
the 24 hour period of stress. Western blot analysis was carried out on protein extracts
obtained at specific time points after the treatment of undifferentiated/differentiated WT or
undifferentiated Parkin overexpressing SH-SY5Y cells with 5mM CCCP over a 24 hour
period (n = 3). Where required, cells were differentiated in 10µM RA for 3 days (10% serum)
followed by 50ng/ml BDNF (no serum) for 3 days prior to treatment with CCCP. Differentiated
cells were highly sensitive to CCCP challenge and a sufficient quantity of extract was only
obtained up to the 12 hour time point. Densitometry was calculated relative to the loading
control. (A) Significant increases in c-Jun levels were observed in all 3 cell lines undergoing
uncoupling. (B) Phosphorylated (S63) c-Jun levels showed more significant elevation in
differentiated cells.. (C) Average values for total c-Jun and phosphorylated (S63) c-Jun levels
were used to calculate the phospho/total c-Jun ratio over 24 hours of uncoupling. (D-E) cDNA
obtained from RNA extracts over the 24h after 5mM CCCP challenge in undifferentiated WT
SH-SY5Y cells was analysed for relative expression of the individual AP-1 genes by qPCR.
Expression levels are relative to the 0h time point. (D) c-JUN expression was regulated in a
biphasic manner upon uncoupling. (E) PARKIN expression was upregulated in response to
mitochondrial uncoupling. (F) BIM expression was upregulated within 1h of uncoupling,
before dropping. qPCR Graphs show 2 independent biological repeats (1
st
 Ð blue, 2
nd
 Ð
orange) with errors bars representing variation between technical replicates within a single
experiment. Statistical significance was determined using a 2way ANOVA (DunnettÕs)
(*p<0.05, **p<0.01, ***p<0.005, ****p<0.001). Quantified levels were compared to levels at
time point 0. Error bars represent SEM (westerns) or SD (qPCR).
 
 
 
 
 
 
 
 
Figure 4: JNK and ERK modulate c-Jun levels in response to different levels of
mitochondrial stress. Western blot analysis was carried out on extracts obtained at different
time points from undifferentiated WT SH-SY5Y cells that were treated with 10µM SP600125
or 1µM FR180204 2h prior to challenge with CCCP. (A) Inhibition of both JNK and ERK
suppressed the increase in c-Jun levels seen in response to 5µM CCCP. (B) Following
challenge with 5µM CCCP, JNK inihibition decreased c-Jun S63 phosphorylation, whereas
ERK inhibition increased it. (C) In response to 30µM CCCP, ERK-induced c-Jun upregulation
was perturbed by JNK activity. (D) ERK activity regulated transient c-Jun S63 phosphorylation
in response to higher levels of uncoupling, while JNK contributed to the regulation of this
phosphorylation (n = 2). Statistical significance was determined using a 2-way ANOVA
(TukeyÕs) relative to the inhibitor vehicle control (DMSO) at each time point (*p<0.05,
**p<0.01, ***p<0.005, ****p<0.001). Error bars represent SEM.
 
 
 
 
Figure 5: JNK promotes apoptosis in differentiated WT SH-SY5Y cells in response to
high levels of mitochondrial stress. Cells were differentiated in 10µM RA for 3 days (10%
serum) followed by 50ng/ml BDNF (no serum) for 3 days in 96-well Operetta plates, then
treated with SP600125 (JNK inhibitor), FR180204 (ERK inhibitor) and/or 100nM epoxomicin
(proteasomal inhibitor) prior to CCCP exposure. Images were captured using an Operetta
imaging system and analysed using Columbus software. Nuclei stained with DAPI (blue) and
cytoplasm with TOTO-3 (cytoplasm). (A) Examples of images captured on the Operetta at
20X magnification. (B) A significant rescue in cell numbers by JNK inhibition was only seen in
cultures challenged with high levels of CCCP (n = 4). (C) MAPK inhibition in differentiated
Parkin overexpressing SH-SY5Y cells (n = 4). (D & E) JNK-mediated apoptosis did not occur
in differentiated WT cells undergoing proteasomal inhibition, but was initiated upon the
addition of mitochondrial uncoupling (n = 4). (F & G) Columbus software was used to analyse
images captured using the Operetta. Mitochondrial clusters on the FITC channel (green)
within the cytoplasm (TOTO3 Ð red) were labelled and counted relative to nuclei on the DAPI
channel. Mitochondrial clustering 3h post-CCCP challenge in differentiated WT SH-SY5Y
cells was perturbed by proteasomal inhibition but not MAPK inhibition (n = 3).  Statistical
significance was determined using a 2-way ANOVA (TukeyÕs) (*p<0.05, **p<0.01, ***p<0.005,
****p<0.001). Comparisons were made between inhibitor-treatment and inhibitor vehicle
control of the same CCCP concentration, unless otherwise indicated by horizontal bars. Error
bars represent SEM.
significance was determined using a 2-way ANOVA (TukeyÕs) (*p<0.05, **p<0.01, ***p<0.005,
****p<0.001). Comparisons were made between inhibitor-treatment and inhibitor vehicle
control of the same CCCP concentration, unless otherwise indicated by horizontal bars. Error
bars represent SEM.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Parkin and c-Jun activity may be functionally linked. (A) Undifferentiated WT
SH-SY5Y cells were treated with 100nM epoxomicin 1h prior to challenge with 5µM CCCP for
up to 6h. Extracts were obtained at required time points for analysis by western blotting and
c-Jun levels were calculated relative to b-actin. (n = 3). (B) Densitometric analysis of western
blots showed c-Jun levels relative to b-actin were comparable with and without 1 hour 100nM
epoxomicin treatment in the absence of CCCP (n = 3). (C) Over a 24h period of uncoupling
following proteasomal inhibition, a massive increase in c-Jun levels was observed from 6h
onwards compared to cells undergoing uncoupling without epoxomicin treatment (n = 3). (D)
In a HEK293 model, expression of different Parkin constructs was induced by tetracycline for
24h. Cells were then treated with 5mM CCCP for 24h and protein extracts used to measure
c-Jun levels by western blotting. Representative western blots for each Parkin mutant are
shown. (F) Quantitative densitometric analysis of these blots was performed (n = 3). c-Jun
levels were compared to those in cells not treated with CCCP or tetracycline for each Parkin
construct unless otherwise shown. T240R appears to exacerbate the c-Jun response.
Statistical significance was ascertained by 2-way ANOVA (BonferonniÕs) (*p<0.05, **p<0.01,
***p<0.005, ****p<0.001). Error bars represent SEM.
Figure 7: Potential regulatory pathways in the neuronal response to mitochondrial
damage in PD. (A) Increased ROS production occurs in damaged mitochondria. Acute bursts
of mitochondrial ROS initiate redox-sensitive signalling as part of normal neuronal function,
with Parkin suppressing mitochondrial MAPK activity. Under these physiological conditions
where, unlike models using uncouplers to induce mitochondrial damage in order to
exaggerate in vivo situations, Parkin is cytoprotective. (B) High levels of stress activates
MAPK signalling, RO accumulation and Parkin-dependent degradation of MCL-1. This leads
to JNK/c-Jun pathways inducing the expression of pro-apoptotic genes such as BIM. Models
using Parkin overexpression models will, however, lower the threshold at which Parkin
promotes apoptosis under uncoupling conditions. (C) Some Parkin mutations antagonise its
stress-induced mitochondrial translocation and resulting suppression of MAPK signalling.
Mitochondrial ROS production increased by mitochondrial JNK activity promotes neuronal
death pathways, which may be exacerbated by the failure of mutant Parkin to initiate
mitophagy.
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Figure S1: Differentiation and Parkin overexpression in SH-SY5Y cells. (A)
Differentiation of SH-SY5Y cells using RA/BDNF resulted in greater observable neurite
outgrowth relative to sequential treatment with RA (10% serum) then RA (0 % serum)
(RA/RA) or RA (10% serum) then TPA (0.5% serum). Images were taken at 40X magnification
to demonstrate morphological changes induced by the 3 methods. (C) Parkin expression
does not affect the proliferation of SH-SY5Y cells (n = 3). Cells were plated at 100,000
cells/ml (2ml/well) and incubated for 72 hours before counting. Counts were analysed using
an unpaired two-tailed t-test. Error bars represent SEM.
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure S2: Immunofluorescence imaging of AP-1 proteins in WT SH-SY5Y cells. Cell
nuclei were stained with DAPI (blue) and AP-1 proteins visualised as red or green. Images
were captured at 100X magnification using a Zeiss Imager Z1 fluorescent microscope
coupled to AxioVision software (scale bar Ð 10µm).
 
 
 
 
 
 
 
 
Figure S3: Immunofluorescence imaging of AP-1 proteins in Parkin overexpressing
SH-SY5Y cells. Cell nuclei were stained with DAPI (blue) and AP-1 proteins visualised as red
or green. Analysis of JunB by this method was not successfully performed and the
experiment was not repeated.  Images were captured at 100X magnification using a Zeiss
Imager Z1 fluorescent microscope coupled to AxioVision software (scale bar Ð 10µm).
 
 
 
 
 
 
 
Figure S4: Modulation of JunB and JunD levels in response to mitochondrial
uncoupling. Western blot analysis was carried out on protein extracts obtained at time points
after the treatment of undifferentiated/differentiated WT or undifferentiated Parkin
overexpressing SH-SY5Y cells with 5mM CCCP over 6 and 24h periods (n = 2).
Differentiated cells were more sensitive to CCCP challenge so a sufficient quantity of extract
was not obtained for the 24h assay. Densitometry was calculated relative to the loading
control. (A) In comparison to WT undifferentiated cells, JunB underwent a more significant
and rapid early increase in levels in Parkin overexpressing cells. No induction was detected in
differentiated cells. TPA induction of JunB was used to confirm the analysis of the correct
band. (B) In WT undifferentiated cells JunB levels peaked at 6h after uncoupling before
decreasing then slowly increasing again to 24h. Parkin overexpression resulted in a greater
increase before levels subsided. (C) The 37kDa (blue) and 41kDa (brown) JunD isoforms
showed similar modulation in response to mitochondrial stress. (D) Parkin overexpression
may repress the later elevation in JunD levels. Statistical significance was determined using a
decreasing then slowly increasing again to 24h. Parkin overexpression resulted in a greater
increase before levels subsided. (C) The 37kDa (blue) and 41kDa (brown) JunD isoforms
showed similar modulation in response to mitochondrial stress. (D) Parkin overexpression
may repress the later elevation in JunD levels. Statistical significance was determined using a
2way ANOVA (DunnettÕs) (*p<0.05, **p<0.01, ***p<0.005). Quantified levels were compared
to levels at time point 0. Error bars represent SEM (37kDa Ð above, 41kDa Ð below).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5: c-Fos and FosB levels increase in response to mitochondrial uncoupling.
Western blot analysis was carried out on protein extracts obtained at time points after the
treatment of undifferentiated/differentiated WT or undifferentiated Parkin overexpressing SH-
SY5Y cells with 5mM CCCP over a 6 or 24h period (n = 2). Differentiated cells were highly
sensitive to CCCP challenge so c-Fos and FosB levels were not assessed for this cell line
over 24h. Densitometry was not performed because proteins were undetectable under basal
conditions. Cells treated with 100mg/ml TPA for 2h were used as a positive control. (A)
Increased c-Fos levels peaking at 3h after uncoupling were detected in undifferentiated and
differentiated WT cells, with higher levels being present in the latter. No increase was
detected in undifferentiated Parkin overexpressing cells. (B) c-Fos levels peaked between 6-
12h after uncoupling in WT undifferentiated cells before subsiding. In Parkin overexpressing
cells increased levels were not seen until 18h post-uncoupling. (C) No early increase in levels
of either FosB isoform was seen in WT cells. Parkin overexpression in undifferentiated cells
resulted in increased levels of both FosB and DFosB by 2h after uncoupling. (D) FosB and
DFosB protein was detected between 6-12h post- uncoupling in WT cells. No protein was
detected in Parkin overexpressing cells, despite having been detected in the 6h assay. A non-
specific band of a molecular weight below DFosB was observed in the WT extracts at all time
points.
Ddetected in Parkin overexpressing cells, despite having been detected in the 6h assay. A non-
specific band of a molecular weight below DFosB was observed in the WT extracts at all time
points.
 
 
 
Figure S6: Fra-1 and Fra-2 undergo regulation in response to CCCP. Western blot
analysis was carried out on protein extracts obtained at time points after the treatment of
undifferentiated/differentiated WT or undifferentiated Parkin overexpressing SH-SY5Y cells
with 5mM CCCP over 6 and 24h periods (n = 2). Differentiated cells were highly sensitive to
CCCP challenge so a sufficient quantity of extract was not obtained for the 24h assay.
Densitometry was calculated relative to the loading control. (A) Fra-1 protein levels remained
relatively constant over the first 6h of uncoupling in all cells examined. (B) A minor decrease
or increase in Fra-1 levels occurred by 24h after uncoupling in WT and Parkin overexpressing
cells respectively. (C) Only minor modulations of Fra-2 levels were seen in all cells after 6h
uncoupling. (D) Fra-2 levels showed a general increase in undifferentiated WT and Parkin
overexpressing cells over 24h of uncoupling. Statistical significance was determined using a
2way ANOVA (DunnettÕs) (*p<0.05). Quantified levels were compared to levels at time point 0.
Error bars represent SEM.
 
Figure S7: Modulation of AP-1 gene expression after mitochondrial uncoupling. cDNA
obtained from RNA extracts over the 24h after 5mM CCCP challenge in undifferentiated WT
SH-SY5Y cells was analysed for relative expression of the individual AP-1 genes by qPCR.
Expression levels are relative to the 0h time point, unless otherwise stated. (A) JUNB and
Figure S7: Modulation of AP-1 gene expression after mitochondrial uncoupling. cDNA
obtained from RNA extracts over the 24h after 5mM CCCP challenge in undifferentiated WT
SH-SY5Y cells was analysed for relative expression of the individual AP-1 genes by qPCR.
Expression levels are relative to the 0h time point, unless otherwise stated. (A) JUNB and
JUND expression in response to CCCP challenge show these genes are induced. (B) c-FOS
and FOSB were modulated more rapidly than FRA-1 and FRA-2 and also showed a biphasic
response that was not observed in the latter. As FOSB mRNA was not detectable under basal
conditions, values are relative to the TPA-induced control for this gene. Graphs show 2
independent biological replicates (1
st
 Ð blue, 2
nd
 Ð orange) (n = 2). Statistical significance was
determined using a 2way ANOVA (DunnettÕs) (*p<0.05, **p<0.01, ***p<0.005, ****p<0.001).
Quantified levels were compared to levels at time point 0 unless otherwise stated by
horizontal bars. Error bars represent SD.
 
 
 
 
 
 
 
 
 
Figure S8: An example of Columbus software analysis of images captured using the
Operetta system. Images were captured using the 20X lens. Nuclei (DAPI Ð blue),
mitochondria (MTCO2 Ð green) and cytoplasm (TOTO-3 Ð red) were labelled for imaging.
Columbus software then calculated the number of mitochondrial ÔspotsÕ or ÔclustersÕ (FITC
channel) per cell (DAPI channel) for every well. Scale bars for both image sizes are 50µM.
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